IRLAB Publishes Interim Report for The Period January - June 2026

GOTHENBURG, SE / ACCESS Newswire / August 26, 2026 / IRLAB Therapeutics AB (STO:IRLAB-A)(FRA:6IRA), a company discovering and developing novel treatments for Parkinson's disease, today announced that the interim report for the period January-June …